{"DataElement":{"publicId":"2753341","version":"1","preferredName":"Cervical Carcinoma Clinical Stage","preferredDefinition":"Text term for the extent of cervical carcinoma within the body, using noninvasive and/or imaging means. [Manually-curated]","longName":"CERV_CA_CLIN_STG","context":"NCIP","contextVersion":"1","DataElementConcept":{"publicId":"2753332","version":"1","preferredName":"Cervical Carcinoma Clinical Stage","preferredDefinition":"Cervical carcinoma may arise from either the exocervical squamous epithelium or the endocervical glandular epithelium.  The major histologic types of cervical carcinoma are: squamous carcinoma, adenocarcinoma, adenosquamous carcinoma, adenoid cystic carcinoma and undifferentiated carcinoma._Relating to the examination and treatment of patients dependent on direct observation.  The term may also refer to the institution (clinic) providing this activity._The extent of a cancer within the body, especially whether the disease has spread from the original site to other parts of the body.","longName":"CERV_CA_CLIN_STG","context":"NCIP","contextVersion":"1","ObjectClass":{"publicId":"2753329","version":"1","preferredName":"Cervical Carcinoma","preferredDefinition":"Cervical carcinoma may arise from either the exocervical squamous epithelium or the endocervical glandular epithelium.  The major histologic types of cervical carcinoma are: squamous carcinoma, adenocarcinoma, adenosquamous carcinoma, adenoid cystic carcinoma and undifferentiated carcinoma.","longName":"C9039","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Cervical Carcinoma","conceptCode":"C9039","definition":"A carcinoma arising from either the exocervical squamous epithelium or the endocervical glandular epithelium. The major histologic types of cervical carcinoma are squamous cell carcinoma and adenocarcinoma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"4E43A631-BC95-0DC4-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-05-28","endDate":null,"createdBy":"REEVESD","dateCreated":"2008-05-28","modifiedBy":"ONEDATA","dateModified":"2008-05-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2753330","version":"1","preferredName":"Clinical Stage","preferredDefinition":"Having to do with the examination and treatment of patients.:The extent of a cancer within the body, especially whether the disease has spread from the original site to other parts of the body.","longName":"C25398:C16899","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Clinical","conceptCode":"C25398","definition":"Relating to the examination and treatment of patients dependent on direct observation.  The term may also refer to the institution (clinic) providing this activity.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Neoplasm Stage","conceptCode":"C16899","definition":"The extent of a cancer in the body.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4E43A631-BCA3-0DC4-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-05-28","endDate":null,"createdBy":"REEVESD","dateCreated":"2008-05-28","modifiedBy":"ONEDATA","dateModified":"2008-05-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008549","version":"1","preferredName":"Involvement and Extent of Disease","preferredDefinition":"indication of the presence and extent of disease.","longName":"INV_AND_EXT_OF_DZ","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22AA815-A017-5261-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4E43A631-BCB4-0DC4-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-05-28","endDate":null,"createdBy":"REEVESD","dateCreated":"2008-05-28","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"2753334","version":"1","preferredName":"Cervical Carcinoma Stage","preferredDefinition":"Cervical carcinoma may arise from either the exocervical squamous epithelium or the endocervical glandular epithelium.  The major histologic types of cervical carcinoma are: squamous carcinoma, adenocarcinoma, adenosquamous carcinoma, adenoid cystic carcinoma and undifferentiated carcinoma._The extent of a cancer within the body, especially whether the disease has spread from the original site to other parts of the body.","longName":"CERV_CA_STG","context":"NCIP","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"12","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Stage IV","valueDescription":"Invasive cancer with tumor spreading to other parts of the body","ValueMeaning":{"publicId":"2753335","version":"1","preferredName":"Invasive cancer with tumor spreading to other parts of the body","longName":"2753335","preferredDefinition":"Invasive cancer with tumor spreading to other parts of the body","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4E43DE18-B50C-1686-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"REEVESD","dateCreated":"2008-05-28","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"4E43DE18-B525-1686-E044-0003BA3F9857","beginDate":"2008-05-28","endDate":null,"createdBy":"REEVESD","dateCreated":"2008-05-28","modifiedBy":"REEVESD","dateModified":"2008-05-28","deletedIndicator":"No"},{"value":"Stage III","valueDescription":"Invasive cancer with tumor spreading to the lower third of the vagina or onto the pelvic wall; tumor may be blocking the flow of urine from the kidneys to the bladder","ValueMeaning":{"publicId":"2753336","version":"1","preferredName":"Invasive cancer with tumor spreading to the lower third of the vagina or onto the pelvic wall; tumor may be blocking the flow of urine from the kidneys to the bladder","longName":"2753336","preferredDefinition":"Invasive cancer with tumor spreading to the lower third of the vagina or onto the pelvic wall; tumor may be blocking the flow of urine from the kidneys to the bladder","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4E43DE18-B531-1686-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"REEVESD","dateCreated":"2008-05-28","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"4E43DE18-B54A-1686-E044-0003BA3F9857","beginDate":"2008-05-28","endDate":null,"createdBy":"REEVESD","dateCreated":"2008-05-28","modifiedBy":"REEVESD","dateModified":"2008-05-28","deletedIndicator":"No"},{"value":"Stage II","valueDescription":"Invasive cancer with tumor extending beyond the cervix and/or the upper two-thirds of the vagina, but not onto the pelvic wall","ValueMeaning":{"publicId":"2753337","version":"1","preferredName":"Invasive cancer with tumor extending beyond the cervix and/or the upper two-thirds of the vagina, but not onto the pelvic wall","longName":"2753337","preferredDefinition":"Invasive cancer with tumor extending beyond the cervix and/or the upper two-thirds of the vagina, but not onto the pelvic wall","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4E43DE18-B556-1686-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"REEVESD","dateCreated":"2008-05-28","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"4E43DE18-B56F-1686-E044-0003BA3F9857","beginDate":"2008-05-28","endDate":null,"createdBy":"REEVESD","dateCreated":"2008-05-28","modifiedBy":"REEVESD","dateModified":"2008-05-28","deletedIndicator":"No"},{"value":"Stage I","valueDescription":"Invasive cancer with tumor strictly confined to the cervix","ValueMeaning":{"publicId":"2753338","version":"1","preferredName":"Invasive cancer with tumor strictly confined to the cervix","longName":"2753338","preferredDefinition":"Invasive cancer with tumor strictly confined to the cervix","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4E43DE18-B57B-1686-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"REEVESD","dateCreated":"2008-05-28","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"4E43DE18-B594-1686-E044-0003BA3F9857","beginDate":"2008-05-28","endDate":null,"createdBy":"REEVESD","dateCreated":"2008-05-28","modifiedBy":"REEVESD","dateModified":"2008-05-28","deletedIndicator":"No"},{"value":"Stage 0","valueDescription":"Cervical Carcinoma in situ","ValueMeaning":{"publicId":"2753339","version":"1","preferredName":"Cervical Carcinoma in situ","longName":"2753339","preferredDefinition":"Carcinoma in situ; Tumor is present only in the epithelium (cells lining the cervix) and has not invaded deeper tissues.","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4E43DE18-B5A0-1686-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"REEVESD","dateCreated":"2008-05-28","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"4E43DE18-B5B9-1686-E044-0003BA3F9857","beginDate":"2008-05-28","endDate":null,"createdBy":"REEVESD","dateCreated":"2008-05-28","modifiedBy":"REEVESD","dateModified":"2008-05-28","deletedIndicator":"No"},{"value":"Stage IVB","valueDescription":"Stage IVB","ValueMeaning":{"publicId":"3104201","version":"1","preferredName":"Stage IVB","longName":"3104201","preferredDefinition":"Distant metastases, including intra-abdominal metastases and/or inguinal lymph nodes","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"87F3C580-0585-1DC3-E040-BB89AD434E7E","latestVersionIndicator":"Yes","beginDate":"2010-06-01","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-06-01","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"87F3C580-059D-1DC3-E040-BB89AD434E7E","beginDate":"2010-06-01","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-06-01","modifiedBy":"ONEDATA","dateModified":"2010-06-01","deletedIndicator":"No"},{"value":"Stage IVA","valueDescription":"Stage IVA","ValueMeaning":{"publicId":"3104202","version":"1","preferredName":"Stage IVA","longName":"3104202","preferredDefinition":"Tumor invasion of bladder and/or bowel mucosa","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"87F3C580-05A8-1DC3-E040-BB89AD434E7E","latestVersionIndicator":"Yes","beginDate":"2010-06-01","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-06-01","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"87F3C580-05C0-1DC3-E040-BB89AD434E7E","beginDate":"2010-06-01","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-06-01","modifiedBy":"ONEDATA","dateModified":"2010-06-01","deletedIndicator":"No"},{"value":"Stage IIIC2","valueDescription":"Stage IIIC2","ValueMeaning":{"publicId":"3104203","version":"1","preferredName":"Stage IIIC2","longName":"3104203","preferredDefinition":"Local and/or regional spread of the tumor; positive para-aortic lymph nodes with or without positive pelvic lymph nodes","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"87F3C580-05CB-1DC3-E040-BB89AD434E7E","latestVersionIndicator":"Yes","beginDate":"2010-06-01","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-06-01","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"87F3C580-05E4-1DC3-E040-BB89AD434E7E","beginDate":"2010-06-01","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-06-01","modifiedBy":"ONEDATA","dateModified":"2010-06-01","deletedIndicator":"No"},{"value":"Stage IIIC1","valueDescription":"Stage IIIC1","ValueMeaning":{"publicId":"3104204","version":"1","preferredName":"Stage IIIC1","longName":"3104204","preferredDefinition":"Local and/or regional spread of the tumor; positive pelvic lymph nodes","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"87F3C580-05EE-1DC3-E040-BB89AD434E7E","latestVersionIndicator":"Yes","beginDate":"2010-06-01","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-06-01","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"87F3C580-0607-1DC3-E040-BB89AD434E7E","beginDate":"2010-06-01","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-06-01","modifiedBy":"ONEDATA","dateModified":"2010-06-01","deletedIndicator":"No"},{"value":"Stage IIIC","valueDescription":"Stage IIIC","ValueMeaning":{"publicId":"3104205","version":"1","preferredName":"Stage IIIC","longName":"3104205","preferredDefinition":"Local and/or regional spread of the tumor; metastases to pelvic and/or para-aortic lymph nodes (Positive cytology has to be reported separately without changing the stage)","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"87F3C580-0611-1DC3-E040-BB89AD434E7E","latestVersionIndicator":"Yes","beginDate":"2010-06-01","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-06-01","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"87F3C580-062A-1DC3-E040-BB89AD434E7E","beginDate":"2010-06-01","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-06-01","modifiedBy":"ONEDATA","dateModified":"2010-06-01","deletedIndicator":"No"},{"value":"Stage IIIB","valueDescription":"Stage IIIB","ValueMeaning":{"publicId":"3104206","version":"1","preferredName":"Stage IIIB","longName":"3104206","preferredDefinition":"Local and/or regional spread of the tumor; vaginal and/or parametrial involvement (Positive cytology has to be reported separately without changing the stage)","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"87F3C580-0634-1DC3-E040-BB89AD434E7E","latestVersionIndicator":"Yes","beginDate":"2010-06-01","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-06-01","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"87F3C580-064C-1DC3-E040-BB89AD434E7E","beginDate":"2010-06-01","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-06-01","modifiedBy":"ONEDATA","dateModified":"2010-06-01","deletedIndicator":"No"},{"value":"Stage IIIA","valueDescription":"Stage IIIA","ValueMeaning":{"publicId":"3104207","version":"1","preferredName":"Stage IIIA","longName":"3104207","preferredDefinition":"Local and/or regional spread of the tumor; tumorinvades the serosa of the corpus uteri and/or adnexae (Positive cytology has to be reported separately without changing the stage)","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"87F3C580-0657-1DC3-E040-BB89AD434E7E","latestVersionIndicator":"Yes","beginDate":"2010-06-01","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-06-01","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"87F3C580-066F-1DC3-E040-BB89AD434E7E","beginDate":"2010-06-01","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-06-01","modifiedBy":"ONEDATA","dateModified":"2010-06-01","deletedIndicator":"No"},{"value":"Stage IB","valueDescription":"Stage IB","ValueMeaning":{"publicId":"3104208","version":"1","preferredName":"Stage IB","longName":"3104208","preferredDefinition":"Tumor confined to the corpus uteri; invasion equal to or more than half of the myometrial","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"87F3C580-067A-1DC3-E040-BB89AD434E7E","latestVersionIndicator":"Yes","beginDate":"2010-06-01","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-06-01","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"87F3C580-0692-1DC3-E040-BB89AD434E7E","beginDate":"2010-06-01","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-06-01","modifiedBy":"ONEDATA","dateModified":"2010-06-01","deletedIndicator":"No"},{"value":"Stage IA","valueDescription":"Stage IA","ValueMeaning":{"publicId":"3104209","version":"1","preferredName":"Stage IA","longName":"3104209","preferredDefinition":"Tumor confined to the corpus uteri; no or less then half myometrial invasion","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"87F3C580-069D-1DC3-E040-BB89AD434E7E","latestVersionIndicator":"Yes","beginDate":"2010-06-01","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-06-01","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"87F3C580-06B5-1DC3-E040-BB89AD434E7E","beginDate":"2010-06-01","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-06-01","modifiedBy":"ONEDATA","dateModified":"2010-06-01","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008549","version":"1","preferredName":"Involvement and Extent of Disease","preferredDefinition":"indication of the presence and extent of disease.","longName":"INV_AND_EXT_OF_DZ","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22AA815-A017-5261-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2753333","version":"1","preferredName":"Cervical Carcinoma Stage","preferredDefinition":"Cervical carcinoma may arise from either the exocervical squamous epithelium or the endocervical glandular epithelium.  The major histologic types of cervical carcinoma are: squamous carcinoma, adenocarcinoma, adenosquamous carcinoma, adenoid cystic carcinoma and undifferentiated carcinoma.:The extent of a cancer within the body, especially whether the disease has spread from the original site to other parts of the body.","longName":"C9039:C16899","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Cervical Carcinoma","conceptCode":"C9039","definition":"A carcinoma arising from either the exocervical squamous epithelium or the endocervical glandular epithelium. The major histologic types of cervical carcinoma are squamous cell carcinoma and adenocarcinoma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Neoplasm Stage","conceptCode":"C16899","definition":"The extent of a cancer in the body.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4E43DE18-B4E7-1686-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-05-28","endDate":null,"createdBy":"REEVESD","dateCreated":"2008-05-28","modifiedBy":"ONEDATA","dateModified":"2008-05-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"FIGO:International Federal of Gynecology and Obstetrics","workflowStatus":"RELEASED","registrationStatus":"Application","id":"4E43DE18-B4F8-1686-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-05-28","endDate":null,"createdBy":"REEVESD","dateCreated":"2008-05-28","modifiedBy":"REEVESD","dateModified":"2010-06-01","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2008601","version":"1","longName":"C3D Domain","context":"CCR","ClassificationSchemeItems":[{"publicId":"2812367","version":"1","longName":"caBIG","context":"CCR"}]},{"publicId":"2182125","version":"1","longName":"CCR Implementation","context":"CCR","ClassificationSchemeItems":[{"publicId":"2811673","version":"1","longName":"C3D","context":"CCR"}]},{"publicId":"2183535","version":"1","longName":"Clinical Trial Mgmt Systems","context":"NCIP","ClassificationSchemeItems":[{"publicId":"2812733","version":"1","longName":"FMISO Study","context":"NCIP"},{"publicId":"2812625","version":"1","longName":"CTMS C3D Adopter Sites","context":"NCIP"},{"publicId":"2812731","version":"1","longName":"U Washington","context":"NCIP"},{"publicId":"2812734","version":"1","longName":"U Washington New CDEs","context":"NCIP"},{"publicId":"2812732","version":"1","longName":"FES Study","context":"NCIP"}]}],"AlternateNames":[],"ReferenceDocuments":[{"name":"FIGO Clinical Stage","type":"Preferred Question Text","description":"FIGO Clinical Stage","url":null,"context":"NCIP"},{"name":"FIGO Stage","type":"Alternate Question Text","description":"FIGO Stage","url":null,"context":"NCIP"}],"origin":"FIGO:International Federal of Gynecology and Obstetrics","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"4E43F26F-0CDA-1E72-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-05-28","endDate":null,"createdBy":"REEVESD","dateCreated":"2008-05-28","modifiedBy":"REEVESD","dateModified":"2011-03-18","changeDescription":"Curated to support U Washington adoption of C3D for FMISO trial.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}